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EVIDENCE-BASED ANSWER 
No evidence supports one method over another in managing uncomplicated gastroesophageal reflux 
disease (GERD) for patients aged >65 years. For those with endoscopically documented esophagitis, 
proton pump inhibitors (PPIs) relieve symptoms faster than histamine H2 receptor antagonists 
(H2RAs) (strength of recommendation [SOR]: B, extrapolation from randomized controlled trials 
[RCTs]). Treating elderly patients with pantoprazole (Protonix) after resolution of acute esophagitis 
results in fewer relapses than with placebo (SOR: B, double-blind RCT). Limited evidence suggests 
that such maintenance therapy for prior esophagitis with either H2RAs or PPIs, at half- and full-dose 
strength,
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 decreases the frequency of relapse (SOR: B, extrapolation from uncontrolled clinical trial). 
Laparoscopic antireflux surgery for treating symptomatic GERD among elderly patients without 
paraesophageal hernia reduces esophageal acidity, with no apparent increase in postoperative 
morbidity or mortality compared with younger patients (SOR: C, nonequivalent before-after study). 
Upper endoscopy is recommended for elderly patients with alarm symptoms, new-onset GERD, or 
longstanding disease (SOR: C, expert consensus; see TABLE). 
Elderly patients are at risk for more severe complications from GERD, and their relative discomfort 
from the disease process is often less than from comparable pathology for younger patients (SOR: C, 
expert consensus). Based on safety profiles and success in the general patient population, PPIs as a 
class are considered first-line treatment for GERD and esophagitis for the elderly (SOR: C, expert 
consensus). 
CLINICAL COMMENTARY 
Teasing out serious disease from routine GERD is a 
challenge in the elderly 
 
Peter  Danis,  MD 
St. John’s Mercy Medical Center, St. Louis, Mo 
Who really needs the invasive workup and expensive medicine, and who needs the simple 
approach? Elderly patients can attribute symptoms to “just indigestion” when there are 
other more serious diseases present (ie, angina, severe esophagitis, stricture, cancer). The 
physician may need a more detailed and patient approach to get the “real” story. Lifestyle 
changes and over-the-counter medications will resolve the majority of GERD symptoms. If 
the simple things don’t work or there are warning signs/symptoms, then a further workup is 
needed. The older patient may then be willing to pay the cost of the long term PPI when 
they know that there is significant pathology and the potential for long term symptom relief. 
  EVIDENCE SUMMARY 
Aggregated data from 2 randomized reflux esophagitis trials conducted in the United Kingdom were analyzed 
with respect to patient age. Comparison of symptom relief and esophageal lesion healing showed that elderly 
patients treated with omeprazole (Prilosec) fared better than those treated with either cimetidine (Tagamet) or 
ranitidine (Zantac).
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 The pooled data involved 555 patients with endoscopically proven reflux esophagitis, 154 
of whom were over the age of 65. After 8 weeks, rates of esophageal healing among the elderly were 70% for 
those receiving omeprazole and 29% for those receiving H2RAs (41% difference; 95% confidence interval [CI], 
26–55), while the rate of asymptomatic elderly patients was 79% for the omeprazole group and 51% for the 
H2RA group (28% difference; 95% CI, 12–44).
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 Patients treated with omeprazole healed faster than those 
taking H2RAs, as shown by endoscopy, and more of them experienced symptom relief. 
A multicenter, randomized, double-blind trial of GERD 
maintenance therapy started with an initial open phase in 
which elderly patients with GERD and documented 
esophagitis were treated and then had documented resolution 
of esophagitis by endoscopy after 6 months. The researchers 
then randomized 105 of these elderly patients to receive 
treatment with either low-dose (20 mg/d) pantoprazole or 
placebo for 6 months. Endoscopy was performed after 12 months for all patients, unless indicated sooner. 
Intention-to-treat analysis showed a disease-free rate of 79.6% (95% CI, 68.3–90.9) in the treatment group, 
compared with 30.4% (95% CI, 18.3–42.4) in the placebo group (number needed to treat [NNT]=2). Symptom 
reports concerning the same patients also suggest a marked drop in symptoms that correlated with healing.
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A prospective, nonequivalence, before-after study compared efficacy of, and complications from, laparoscopic 
surgery for symptomatic GERD between younger and older (≥65 years) patients. The investigators examined 
postoperative morbidity and mortality for 359 patients referred for laparoscopic surgery, either a partial or 
Nissen (full) fundoplication. They excluded those requiring more extensive surgery or repair of paraesophageal 
hernia. The 42 elderly patients had a higher mean American Society of Anesthesiologists score compared with 
the younger patients, reflecting higher preoperative comorbidity, but were similar with regard to weight and 
gender. 
Before surgery, investigators performed 24-hour ambulatory pH monitoring. Preoperative exposure times to a 
pH below 4 (TpH <4) were similar for the younger and older patients (median 14.2% and 13.9%, respectively). 
Postoperative complication rates were similar for both groups. No deaths occurred. Minor postoperative 
complications involved 7% of the elderly patients and 6% of the younger group. The 24-hour pH monitoring 
scores showed improvement at 6 weeks after surgery for both groups, with the median TpH <4 at 1.1% (95% 
CL, 0.5) in the elderly vs a median of 1.8% (95% CL, 1.9) in the younger patients. At 1 year postoperatively, the 
values were also similar between the two groups; the median TpH <4 (95% CL) were 1.4% (1.5) in the elderly 
group and 1.2% (0.6) in the younger patient group. 
FAST TRACK 
Based on safety profiles and 
success in the general 
population, PPIs as a class are 
first-line treatment for GERD in 
the elderly 
 
The results of this study should be interpreted with caution, however. The study design is prone to bias, the 
patients had relatively low symptom scores at baseline, and sicker patients may have been excluded during the 
referral process.
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TABLE 
Warning signs and symptoms of dyspepsia and GERD that suggest complicated disease 
or more serious underlying process
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Dysphagia 
Unexplained weight loss 
History of gastrointestinal bleeding 
Early satiety 
Iron deficiency anemia 
Vomiting 
Odynophagia (sharp substernal pain on swallowing) 
Initial onset of heartburn-like symptoms after the age of 50 years 
History of immunocompromised state 
Anorexia 
Recommendations from others 
The Veterans Health Affairs/Department of Defense clinical practice guidelines recommend differentiating 
GERD (feelings of substernal burning associated with acid regurgitation) from dyspepsia (chronic or recurrent 
discomfort centered in the upper abdomen), of which GERD is a subset.
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 The guidelines recommend 
gastroenterology consultation or upper endoscopy to rule out neoplastic or pre-neoplastic lesions if alarm 
symptoms (TABLE) suggesting complicated GERD are present.
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The Institute for Clinical Systems Improvement guidelines on 
dyspepsia and GERD recommend that all patients aged ≥50 
years with symptoms of uncomplicated dyspepsia undergo 
upper endoscopy non-urgently because of the increased 
incidence of peptic ulcer disease, pre-neoplastic lesions, 
malignancy, and increased morbidity out of proportion to 
symptoms that are more common in an older patient 
population. The guidelines also recommend endoscopy for patients aged ≥50 years with uncomplicated GERD 
and the presence of symptoms for greater than 10 years because of the increased risk of pre-neoplastic and 
neoplastic lesions, including Barrett’s esophagus.
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